Related Experiment Video
Updated: Dec 18, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
A Review of Cardiac Complications in Coronavirus Disease 2019
Romil Singh1, Rahul Kashyap2, Anneka Hutton3
1Internal Medicine, Metropolitan Hospital, Jaipur, IND.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the cause of COVID-19, is linked to myocardial injury and other cardiac issues. This review examines COVID-19
Area of Science:
- Cardiology
- Infectious Diseases
- Genetics
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, causing coronavirus disease 2019 (COVID-19), is associated with acute myocardial injury, cardiomyopathy, and myocarditis.
- Myocardial involvement in COVID-19 patients may increase the risk of severe illness.
- Cardiomyopathies are a diverse group of myocardial diseases characterized by mechanical and/or electrical dysfunction, often with genetic origins, classified into genetic, mixed, and acquired types.
Purpose of the Study:
- To review current information on cardiac complications associated with COVID-19.
- To explore potential cardiovascular complications in severe COVID-19 cases due to the inflammatory response.
Main Methods:
- Literature review of recent studies and publications.
- Synthesis of emerging data on COVID-19 and cardiovascular manifestations.
Main Results:
- COVID-19 is associated with various cardiac complications, including myocardial injury, cardiomyopathy, and myocarditis.
- Patients with COVID-19 and myocardial involvement face a higher risk of severe disease.
- The inflammatory response in severe COVID-19 may precipitate other cardiovascular issues.
Conclusions:
- COVID-19 poses significant risks to cardiovascular health.
- Further research is needed to fully understand and manage cardiac complications in COVID-19 patients.
- Prompt recognition and management of cardiac involvement are crucial for improving outcomes in COVID-19 patients.
Abstract:
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has shown an association with acute myocardial injury, cardiomyopathy, and myocarditis. Individuals with myocardial involvement in association with the coronavirus disease 2019 (COVID-19) may be at increased risk of developing severe illness. Cardiomyopathies are a heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually exhibit inappropriate ventricular hypertrophy or dilation and are due to a variety of causes that frequently are genetic. It has been primarily divided into three subsets: genetic, mixed, and acquired cardiomyopathy. We anticipate that, because of the high inflammatory response, other cardiovascular complications may also occur in COVID-19 patients with severe symptoms. This review explores new information as it pertains to COVID-19 and cardiac complications.
Related Concept Videos
Introduction Cardiac Emergencies
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis III: Medical Management
Cardiomyopathy I: Introduction and Classification

